title: Diabetes and dyslipidaemia.
abstract: Diabetes and dyslipidaemia are two common comorbid conditions encountered in clinical practice. This review discusses the screening, investigations, non-pharmacological and pharmacological management of dyslipidaemia in type 2, type 1, and pre-diabetes, with a view to improving cardiovascular outcomes. The paper highlights certain simple dos and don'ts which may be useful for our cultural and clinical setting.
authors.affiliation: Department of Endocrinology, Bharti Hospital & BRIDE, Karnal, India. brideknl@gmail.com
authors.forename: Sanjay
authors.initials: S
authors.lastname: Kalra
authors.forename: Ambika G
authors.initials: AG
authors.lastname: Unnikrishnan
mesh_terms: D003920:Diabetes Mellitus / Q000453:epidemiology* / Q000628:therapy*; D050171:Dyslipidemias / Q000150:complications / Q000453:epidemiology / Q000628:therapy; D014943:Global Health; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D009017:Morbidity / Q000639:trends; D026741:Physical Therapy Modalities
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors